DocDollars

G1 Therapeutics, Inc.

NC · United States · Reporting entity ID 100000916825

Total reported 2019–2025
$19.7M
#321 of 2,960 reporting companies — 0% of all reported industry payments
$1.47M in general payments across 7,400 records, plus $18.3M in research funding across 3,771 records.

How it breaks down

General payments $1,471,553
Research funding $18,255,276

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

G1 Therapeutics, Inc. reported $19.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #321 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 7,400 general payment records and 3,771 research records were filed.

Common questions about G1 Therapeutics, Inc.

How much has G1 Therapeutics, Inc. paid US doctors?

G1 Therapeutics, Inc. reported $19,726,829 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,471,553 in general payments, $18,255,276 in research funding.

How does G1 Therapeutics, Inc. rank among drug and device companies?

It ranks #321 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from G1 Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.